Goeltz II Robert C.
SEC CIK 1653881 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RCUS | Arcus Biosciences, Inc. | CFO | 84.2K | — | $1.15M | 18 | 2021-12-16 | 2026-05-11 |
Most active insiders at RCUS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Jaen Juan C. | Pres | — | $9.22M |
| 2 | Jarrett Jennifer | COO | — | $2.17M |
| 3 | ROSEN TERRY J | CEO, Dir | — | $1.20M |
| 4 | Goeltz II Robert C. | CFO | — | $855.9K |
| 5 | Azoy Alexander | CAO | — | $432.5K |
| 6 | Tang Carolyn C. | GC | — | $318.5K |
| 7 | Markus Richard | Chief Medical Off | — | $210.1K |
| 8 | Ribas Antoni | Dir | — | — |
| 9 | Lambert Nicole | Dir | — | — |
| 10 | Lacey David L. | Dir | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-12 16:09 | 2026-05-11 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | S - Sale | $25.63 | -7,763 | 84.2K | -8% | -$199.0K |
| D | 2026-01-26 | 2026-01-23 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | A - Grant | $0.00 | +24.0K | 91.9K | +35% | $0 |
| T | 2026-01-02 | 2025-12-31 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | S - Sale | $23.38 | -6,552 | 67.9K | -9% | -$153.2K |
| M | 2025-12-18 | 2025-12-16+ | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | S - Sale | $22.01 | -12.7K | 80.4K | -14% | -$278.7K |
| 2025-11-26 | 2025-11-26 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | S - Sale | $25.00 | -5,000 | 87.1K | -5% | -$125.0K | |
| 2025-10-29 | 2025-10-28 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | S - Sale | $20.00 | -5,000 | 92.1K | -5% | -$100.0K | |
| D | 2025-01-27 | 2025-01-23 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | A - Grant | $0.00 | +37.0K | 97.1K | +62% | $0 |
| 2025-01-03 | 2024-12-31 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | S - Sale | $15.00 | -3,594 | 60.1K | -6% | -$53.9K | |
| 2024-12-17 | 2024-12-15 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | F - Tax | $16.08 | -10.1K | 63.7K | -14% | -$162.4K | |
| A | 2024-02-23 | 2024-01-23 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | A - Grant | $0.00 | +22.0K | 73.8K | +42% | $0 |
| D | 2024-01-25 | 2024-01-23 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | A - Grant | $0.00 | +21.3K | 73.1K | +41% | $0 |
| 2024-01-04 | 2024-01-02 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | S - Sale | $20.00 | -2,004 | 51.8K | -4% | -$40.1K | |
| M | 2023-12-20 | 2023-12-18+ | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | D - Sale to Iss | $17.92 | -5,557 | 56.6K | -9% | -$99.6K |
| 2023-06-09 | 2023-06-07 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | S - Sale | $20.04 | -4,049 | 59.4K | -6% | -$81.1K | |
| D | 2023-01-25 | 2023-01-23 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | A - Grant | $0.00 | +34.0K | 63.4K | +115% | $0 |
| M | 2022-12-16 | 2022-12-16 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | S - Sale | $30.75 | -2,453 | 12.0K | -17% | -$75.4K |
| D | 2022-03-10 | 2022-03-08 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | A - Grant | $0.00 | +15.5K | 22.5K | +221% | $0 |
| M | 2021-12-20 | 2021-12-16+ | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | S - Sale | $40.12 | -1,106 | 7,019 | -14% | -$44.4K |
Purchase Sale Sale after option exercise All abbreviations